MEI Pharma, Inc. (NASDAQ:MEIP) is one of the hot penny stocks to invest in now. On July 18, MEI Pharma, Inc. (NASDAQ:MEIP) ...

MEI Pharma unveils bold $100M Litecoin treasury plan with Titan, GSR, Litecoin Foundation, expanding altcoin adoption beyond ...

MEI Pharma raises $100 million to buy Litecoin, boosting stock value and signaling confidence in LTC's future growth.

GSR, crypto’s capital markets partner, today announced an investment and strategic partnership with MEI Pharma, Inc.

In a bold move that’s redefining crypto’s relationship with traditional finance, MEI Pharma, a Nasdaq-listed company known ...

MEI Pharma, a publicly traded pharmaceutical company, closed a $100 million private placement to turn itself into a litecoin ...

MEI Pharma unveils a $100M Litecoin treasury initiative, gaining Litecoin Foundation support and boosting shares 50% intraday ...

MEI Pharma launches $100M Litecoin Treasury plan with Charlie Lee joining the board and backing from major crypto partners ...

MEI Pharma (MEIP) just threw Wall Street a curveball by swapping part of its cash pile for Litecoin (LTC) and inviting ...

MEI Pharma, Inc. (NASDAQ:MEIP) stock is trading higher on Friday, with a session volume of 35.64 million compared to the ...

LTC gained more than 12% in the past 24 hours, following two major institutional announcements. First and foremost, Luxxfolio ...

Over the last three years MEI Pharma, Inc. has shrunk its earnings per share by an average of 24% per year (measured with a line of best fit). It achieved revenue growth of 185% over the last year.